ALMKT:EPA
Mauna Kea Technologies SA
€ 0.092
arrow_downward
-0.76%(-0.00070) Siku 1
16 Nov, 15:08:55 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALMKT...
Fungua
€ 0.09
Juu
€ 0.09
Chini
€ 0.09
Mtaji wa soko
18.34M
Wastani wa kiasi cha mauzo
elfu 484.45
Kiasi cha mauzo ya hisa
elfu 358.65
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.78
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Fungua
€ 0.09
Juu
€ 0.09
Chini
€ 0.09
Mtaji wa soko
18.34M
Wastani wa kiasi cha mauzo
elfu 484.45
Kiasi cha mauzo ya hisa
elfu 358.65
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.78
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
The Defiant
·
dakika 25 zilizopita
NYSE Parent ICE Weighs Becoming a Solana Validator
Benzinga
·
dakika 43 zilizopita
A $1.65 Billion Buyout Deal Puts a Spotlight on PolyPid Ahead of Its FDA Decision (NASDAQ: PYPD)
CNBC
·
dakika 22 zilizopita
Morgan Stanley is out with its 2027 outlook for equities. Here’s what the bank expects
TradingView
·
dakika 45 zilizopita
QCLS: Optical-computing pivot meets steep losses, funding needs and Nasdaq listing risk
Wasifu
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Kuhusu Mauna Kea Technologies SA
Afisa Mkuu Mtendaji (CEO)Sacha Loiseau
Wafanyakazi56
Lilianzishwa2000
Makao makuu-
SektaHealth Care
Sekta-
Tovutimaunakeatech.com